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FTIRAs one of its primary physiological functions, sPLA2-IIA appears to act as an antibacterial agent. In particular,
sPLA2-IIA shows high activity towards Gram-positive bacteria such as Staphylococcus aureus (S. aureus). This
antibacterial activity results from the preference of the enzyme towards membranes enriched in anionic
lipids, which is a common feature of bacterial membranes. An intriguing aspect observed in a variety of
bacterial membranes is the presence of a broad but cooperative lipid chain melting event where the lipids in
the membrane transition from a solid-ordered (so) into a liquid-disordered (ld) state close to physiological
temperatures. It is known that the enzyme is sensitive to the level of lipid packing, which changes sharply
between the so and the ld states. Therefore, it would be expected that the enzyme activity is regulated by the
bacterial membrane thermotropic behavior. We determine by FTIR the thermotropic lipid chain melting
behavior of S. aureus and ﬁnd that the activity of sPLA2-IIA drops sharply in the so state. The activity of the
enzyme is also evaluated in terms of its effects on cell viability, showing that cell survival increases when the
bacterial membrane is in the so state during enzyme exposure. These results point to a mechanism by which
bacteria can develop increased resistance towards antibacterial agents that act on the membrane through a
cooperative increase in the order of the lipid chains. These results show that the physical behavior of the
bacterial membrane can play an important role in regulating physiological function in an in vivo system.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The physical state of a cell membrane is susceptible to variations in
temperature. This susceptibility is partly determined by the physical
behavior of the lipid components in the membrane. In the absence of
cholesterol, the two predominant lamellar states for the lipids in cell
membranes are the solid-ordered (so) and the liquid-disordered (ld).
These two lipid states present sharp differences in packing, organi-
zation, and lateral diffusion [1]. In the case of a one-component lipid
system, a sharp chain melting transition is observed between the so
and the ld states [2,3]. For a pure model system, this would be
considered a phase transition separating two distinct phases. Bacterial
membranes are complex multicomponent systems lacking cholesterol.
For this reason, instead of sharp phase transitions, bacterial
membranes present broad so/ldmelting events. These melting events
have been measured in a variety of bacterial species such as Achole-
plasma laidlawii (A. laidlawii) [4,5] and Escherichia coli (E. coli) [6,7]
and are expected to result in the formation of a domain structure
within a broad temperature range [3,8,9].mpo), cleidy@uniandes.edu.co
ll rights reserved.While domain formation has been extensively studied in eukary-
otic cells, in the case of bacterial membranes, the consequences of so/
ld coexistence on bacterial function have not been explored in detail
[10,11]. Owing to its increased rigidity, lipids in the so state do not lend
themselves well to several aspects of bacterial function such as cell
division. For example, bacterial growth rates drop sharplywhen the so
content of the cells is too high [12]. It is therefore intriguing to explore
why an so/ld cooperative melting event is present in bacterial
membranes close to their bacterial grown temperature, and whether
this cooperative event presents any functional advantages for bacteria.
We investigate the relationship between bacterial membrane
lipid chain melting behavior and sPLA2-IIA activity. The PLA2 sub-
types catalyze the hydrolysis of the sn-2 ester bond in glyceropho-
spholipids, yielding free fatty acids and lysophospholipids [13]. The
ﬁrst nonpancreatic mammalian PLA2 to be reported was a secretory
14-kDa calcium-dependent PLA2 classiﬁed under the IIA group
[14,15]. sPLA2-IIA is closely related to the inﬂammatory process,
being involved in many acute and chronic inﬂammatory diseases
[16,17]. One of the distinguishing characteristics of sPLA2-IIA is its
binding speciﬁcity towards membranes enriched in anionic lipids
[18,19]. The enzyme shows practically no activity towards neutral
membranes [20,21]. Owing to the high anionic lipid content of
bacterial membranes (mainly phosphatidylglycerol), the speciﬁcity
Fig. 1. Thermotropic lipid melting behavior of S. aureus measured by monitoring the
CH2 symmetric stretch vibration by FTIR. The solid line shows a Savitzky–Golay
smoothing of the experimental data (closed circles). The ﬁrst derivative of the
experimental data (dashed line) shows two cooperative (so/ld) melting events
centered at 15.4 °C and 33.2 °C.
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antibacterial agent during the inﬂammatory response [22,23].
Since the ability of a lipid to enter the active site of the enzyme is
strongly inﬂuenced by neighbor–neighbor interactions, the activity of
PLA2 has also been shown to be highly sensitive to the level of lipid
packing [24–27]. The appearance of defects generated by the presence
of so/ld interfaces has also been shown to generate increased activity
in model systems [9,25,26,28–30]. However, when the anionic lipid
content is high, sPLA2-IIA activity appears to be only regulated by the
level of lipid packing. This has been observed in model membranes
presenting high anionic lipid content, where the enzyme shows
higher activity in the ld regime compared to the so regime [25]. Since
bacterial membranes present high levels of anionic lipid content, we
expect that sPLA2-IIA will be mainly sensitive to the bacterial lipid
chain melting behavior [31].
In this work, we investigate, through FTIR, the lipid chain melting
behavior of Staphylococcus aureus membranes in vivo. We then show
that the lipid chain melting behavior of the bacterial membrane
regulates the hydrolytic activity of sPLA2-IIA contained in tear ﬂuid
through thermotropic changes in the lipid membrane phases. The
results show that bacterial lipid chain order can modulate resistance
toward a speciﬁc membrane active antibacterial agent, sPLA2-IIA . In
the context of a recent increase in resistance of Gram-positive bacteria
to some antibacterial agents, a deeper understanding of how the
bacterial lipid chain melting behavior can regulate resistance may
lead to the development of improved strategies for the treatment of
bacterial infections.
2. Materials and methods
The reagents for cell culture were purchased from Oxoid (Cam-
bridge UK). The synthetic lipids were purchased from Avanti Polar
Lipids (Alabaster AL). All the reagents and lipids were used without
further puriﬁcation. S. aureuswasgrown in Petri disheswith 15ml of LB
media in agar (15 g/l agar, 10 g/l triptone, 10 g/l NaCl, and 5 g/l yeast)
at 37 °C during 12 hours. Cells were collected by scraping the surface of
the LB plates with a sterile spatula. For the samples used on FTIR
measurements, the cell mass scraped from the LB plates is smeared on
the FTIR windows. For the ﬂuorometer measurements, we used a S.
aureus-rich medium that was made by diluting the cell mass in a
ratio of 6 mg in 1 ml of PLA2 activity buffer (PAB). To prepare the PAB
buffer, we used 0.01 mM EDTA, 0.03 mM CaCl2 and 110mMKCl, 5 mM
K2HPO4, 5 mM KH2PO4, in 100 ml of water and adjusted the pH to 7.5
with solutions of 1 M of K2HPO4 and KH2PO4. In addition, we use a
standard PBS buffer at pH 7.5 for thewashing steps during FTIR sample
preparation. Human tear ﬂuid was used as a source for PLA2 as
described previously [25]. In brief, human volunteers are exposed to
onion fumes and tears are collected with a micropipette. A common
stock of tear ﬂuid was generated by collecting tears from at least ﬁve
individuals. Tears are aliquoted and stored at −20 °C. These aliquots
are thawed immediately before use.
2.1. FTIR measurements
The thermotropic chain melting behavior of native bacterial
membranes was measured by monitoring the CH2 symmetric stretch
vibration (centered around 2853 cm−1) by FTIR. Twenty microliters
of bacteria was directly taken from LB plates and smeared onto a Ca2F
window, which was placed within a home-built Peltier temperature
controller inside of the FTIR chamber (Nexus 2000, Thermo Nicolet,
MA). Eighty spectrograms were acquired for each temperature point,
and the temperature was ramped between 0 °C and 40 °C at 1 °C per
minute. The CH2 symmetric stretch band is monitored as a function of
temperature. To determine the band position, we took the second
derivative and determined the average of 80% band intersects within a
window of 20 wave numbers (from 2860 to 2840 cm−1). Trend lineswere determined by applying a spline Savitzky–Golay type of 13
points to the original data points. Cooperative thermal events were
determined by ﬁnding the maxima in the ﬁrst derivative of the trend
line determined by the Savitzky–Golaymethod. The smoothing allows
us to recognize the general features of the thermotropic behavior.
Fig. 1 shows that the smoothing procedure does not change the
overall thermotropic behavior of the bacterial membrane. The FTIR
scan time used to measure the bacterial phase behavior (at 1 °C per
minute) is around 40 minutes. The bacteria are placed in the FTIR
window in the absence of growth media. The division rate for
S. aureus is about 60 minutes. Therefore, we do not expect any growth
or readaptation to occur during the measurements by FTIR.
To evaluate by FTIR how the activity of sPLA2-IIA modiﬁes the
thermotropic phase behavior of S. aureus, 100 μl of bacteria was
directly taken from LB plates, resuspended in 1 ml of PBS, and
centrifuged at 6000 rpm for 5 minutes; the pellet was again
resuspended in 1 ml of the PAB buffer. Twenty microliters of
human tear ﬂuid was added [32,33] to the suspension and agitated
gently at each ﬁxed temperature (approximately 0.07 nM of sPLA2-IIA
per sample) for a period of 30 minutes. The hydrolysis was stopped
with the addition of 30 μl of 10 μM EDTA. For each sample, we
performed a control with the same buffer conditions, but in the
absence of the enzyme to guarantee that the hydrolysis buffer does
not affect the thermotropic character of the bacterial membrane.
Samples were then centrifuged at 6000 rpm for 5 minutes to obtain
the pellet (approximately 20 μl of pellet) for FTIR analysis. For the
measurements regarding the change in the bacterial phase behavior
induced by sPLA2-IIA treatment, bacterial cells were washed before
treatment and placed in a hydrolysis buffer. This buffer does not
contain growth media, which rules out the possibility for the bacteria
to quickly divide and adapt during the treatment.
2.2. Calcein-enclosed 1,2-di-O-octadecyl-sn-glycero-3-phosphocholine
(1,2-di-O-SPC) liposomes
This method is described in a previous publication [25,34]. Brieﬂy,
an appropriate amount of calcein (50 mM ﬁnal concentration before
adding to lipids) was dissolved in 5 ml of 1 M NaOH. After the calcein
was fully dissolved, 2.5 ml of PAB buffer was added together with 5ml
of deionizedwater. The solutionwas then pH-adjusted to 7.5 with 1M
HCl dropwise to avoid precipitation. Deionized water was then added
to bring the calcein buffer to a ﬁnal volume of 25 ml. 1,2-di-O-SPC
unilamellar vesicles were prepared as follows: The dry lipids were
dispersed in the calcein buffer to a ﬁnal concentration of 10 mM.
Aqueous multilamellar lipid dispersions were prepared by repeated
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multilamellar vesicles were extruded using a hand held extruder
(Avanti Polar Lipids, Alabaster, AL) 13 times through a 100-nm-poresize polycarbonate ﬁlter (Whatman, Clifton, NJ), forming large
unilamellar vesicles with a narrow size distribution. The extruder
temperature was regulated using a water bath andwas set to 65 °C for
all samples. Untrapped calcein was removed from the liposome
suspension by gel ﬁltration through a column packed with Sephadex
G-50 using the PAB buffer as an eluent.
2.3. Measurement of sPLA2-IIA activity through indirect calcein release
from 1,2-di-O-SPC large unilamellar vesicles
As described in a previous publication [25,34], sPLA2-IIA activity
was measured by monitoring the release of calcein encapsulated in a
self-quenching concentration (50 mM) from 1,2-di-O-SPC large
unilamellar vesicles (100 nm). The 1,2-di-O-SPC vesicles are not
hydrolyzed by sPLA2-IIA, but, when added together with S. aureus
bacteria, the release of their calcein content is triggered by the
hydrolysis products. The 1,2-di-O-SPC vesicles have a high phase-
transition temperature (Tm≈56 °C). Therefore, within our experi-
mental temperature range, they are in a stable nonleaky regime. For
every data point at a ﬁxed temperature between 0 and 40 °C, 1800 μl of
PAB buffer was added to a plastic cuvette. S. aureus-rich mediumwith
an approximate cell count of 1×109 colony-forming units (CFU)/ml
was prepared by resuspending 6 mg of cell mass from the LB plates in
1 ml of PAB. Two hundred microliters of the enriched media was
added to the cuvette, after which 100 μl of reporter vesicles with
calcein (100 nm of radii) was added. Twenty microliters of human
tears was added to the cuvette after 500 seconds to allow for thermal
equilibration. Fluorescence measurements were performed in a pc1
ﬂuorometer (ISS, Urbana, IL). Excitation and emission channels were
set at 490 nm and 515 nm, respectively, and the emission ﬂuorescence
was recorded as a function of time (Fig. 2a). The temporal evolution of
the ﬂuorescence intensity was recorded for 3500 seconds.
2.4. S. aureus cell viability
To measure cell viability, we used the method of Miles and Misra
[35]. This is done by diluting and plating the bacterial suspension on
LB plates. After appropriate incubation, colony-forming units (CFU)
are enumerated, and concentration of viable cells is recorded. This
procedure was performed for sPLA2-IIA treatments at different
temperatures. All viability measurements were reported with respect
to a control sample with precisely the same thermal history as the
sPLA2-IIA-treated sample. The only difference between the control
and the treated sample is the absence of sPLA2-IIA. In addition, with
the absence of growth media due to the washing step, no growth or
readaptation is expected during the sPLA2-IIA treatment step.
3. Results
3.1. Measuring the thermotropic lipid chain melting behavior in
S. aureus membranes
Fig. 1 shows a plot of the CH2 symmetric stretch as a function of
temperature of S. aureus in vivo in the temperature range between 0
and 40 °C. Cells were originally grown at 37 °C before measuring the
lipid chain melting behavior. The shift in the CH2 stretch waveFig. 2. Enzymatic activity in relation to bacterial lipid melting behavior. (a)
Measurement of sPLA2-IIA enzymatic activity towards S. aureus by monitoring calcein
release of reporter vesicles of 1,2-di-O-SPC induced by hydrolysis products at 4
different temperatures as measured by following the ﬂuorescence intensity I(t) as a
function of time. The arrow shows the time point at which sPLA2-IIA was added. (b) An
Arrhenius plot of enzyme activity shows that the enzyme activity diverges from a
classic Arrhenius behavior. (c) Superposition of lipid melting behavior of S. aureus as
measured by FTIR (solid line) and sPLA2-IIA hydrolytic activity (closed circles) as a
function of temperature. (d) Correlation between enzymatic activity and the CH2
stretch wave number.
Fig. 3. Comparison between cell viability (closed circles) and sPLA2-IIA activity (closed
triangles) as a function of temperature. An increase in cell viability is observed when
cells are treated at temperatures below the main so/ld melting cooperative event.
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lipid acyl chains, which increases as the membrane lipids melt [4–
9,28–30,36–38]. For this reason, the wave number is a good indicator
of the lipid chain order within the membrane. While single-lipid
systems show a sharp shift in the CH2 stretch at their melting
temperatures, the CH2 stretch in bacterial membranes shifts within a
broader temperature range. This is a trait of the thermotropic phase
behavior in live cells due to their complex lipid composition. The CH2
stretch has been previously used for reporting the lipid chain melting
behavior in Gram-negative bacteria [39].
Fig. 1 also shows the ﬁrst derivative of the CH2 stretch as a function
of temperature, which allows us to identify the main cooperative
events in the bacterial lipid phase behavior. The S. aureus membrane
presents two clear cooperative events centered at 15.4±0.1 °C and
33.2±0.1 °C. The position of these thermal events was determined by
averaging 10 independent FTIR measurements of the in vivo bacterial
strain under the same growth conditions (see Table 1, Supplementary
information). The cooperative event that appears around 33°C is
consistently observed in all the samples that were scanned. However,
this event is very subtle and does not appear to have an inﬂuence on
the activity of the enzyme.
Previously published reports on the membrane composition of
S. aureus show that the bacterial membrane is mostly composed of
a family of phosphatidylethanolamines (PEs), phosphatidylglycerols
(PGs), and cardiolipin (CL) [31,40]. Cardiolipin is characterized by
havingmelting temperatures above 40 °C, while PEs and PGs present a
range of phase transitions between 0 and 40 °C. Therefore, the
cooperative event around 15 °C is most likely related to a population
enriched in PEs and PGs [41].
3.2. Regulation of sPLA2-IIA activity through the thermotropic lipid chain
melting behavior in S. aureus
After determining the characteristic melting events in S. aureus,
we proceed to study the interrelation between the hydrolytic activity
of sPLA2-IIA and the thermotropic behavior of the bacterial membrane
in vivo. Since the enzyme requires calcium as a cofactor for its
hydrolytic activity [42,43], we tested whether the calcium content in
the buffer could inﬂuence the bacterial lipid melting behavior,
showing no signiﬁcant change in the position and shape of the
melting events (data not shown).
In Fig. 2, we measured the activity of the enzyme at different ﬁxed
temperatures on S. aureus bacteria by monitoring the release of
calcein from reporter unilamellar vesicles of nonhydrolyzable 1,2-di-
O-SPC enclosing self-quenching concentrations of calcein. The release
of hydrolysis products during the hydrolytic event induces the release
of calcein from the reporter vesicles. This methodology has been
shown to be an effective indirect method for measuring sPLA2-IIA
activity [25,34]. Fig. 2a shows calcein release traces at four different
temperatures after the enzyme is added at 150 seconds. The enzyme is
observed to act immediately without a noticeable lag time. A lag time
is usually observed before a hydrolytic burst in activity for
zwitterionic membranes by snake venom PLA2 [28,44]. However,
when the target membrane is enriched in anionic lipids and in the
presence of lipid mixtures, the lag time is sharply reduced. It is clear
from Fig. 2a that the activity of the enzyme increases with
temperature. We expect that this increase in activity is related to
the phase behavior of the bacterial membrane. However, to conﬁrm
that this increase in enzyme activity does not simply follow an
Arrhenius law [25], in Fig. 2b, an Arrhenius plot is presented. For this
methodology, activity is traditionally reported by measuring the
initial calcein release rate at each temperature [25,34]. The plot shows
that the enzyme activity does not follow a linear relation expected for
a simple thermal dependence of the activity.
Fig. 2c presents a superposition of the enzymatic activity and the
lipid melting behavior of S. aureus, showing that the activity followsthe lipid melting behavior closely. This is clearly observed in Fig. 2d,
which shows a correlation between activity and the CH2 stretch wave
number in S. aureus. These results show that sPLA2-IIA is closely
regulated by the lipid melting behavior of the bacterial membrane.
Fig. 3 shows the variation in cell viability as a function of sPLA2-IIA
treatment temperature. We measure cell viability by the Miles–Misra
method, which reports a count of surviving CFUs after a 30-minute
treatment andquenchingof the reaction throughdilution (see Section2),
where the control count at each temperature was done in the hydrolysis
buffer without enzyme.
Fig. 3 shows that at lower temperatures, where sPLA2-IIA activity is
reduced, cell viability is approximately 60% after a half-hour
treatment with the enzyme. At higher temperatures, where the
enzyme activity is high, the level of viability decreases to around 35%.
There is a sharp change in cell viability close to the mid point of the
main phase transition (15.4 °C). Clearly, cell survival is strongly
dependent on the lipid melting behavior of the bacterial membrane,
showing a sharp reduction of the bactericidal activity of sPLA2-IIA as
the lipids in the membrane enter the so state at lower temperatures.
3.3. sPLA2-IIA induced membrane restructuring in S. aureus
When treated with nonlethal levels of sPLA2-IIA, S. aureus has been
shown to be able to tolerate a high level of sPLA2-IIA hydrolysis
without loss in cell viability [45,46]. The bacterial cells appear to
respond to the hydrolytic insult by recycling hydrolysis products and
resynthesizing lost lipids. However, the accumulation of hydrolysis
products is likely to alter the physical state of the target membrane
[45,47]. In the case where the level of lipid ﬂuidity is affected by the
accumulation of hydrolysis products, the hydrolytic activity may
curtail vital processes such as cell division that require a ﬂuid
membrane [12]. We are interested in investigating, by FTIR, how the
physical state of the bacterial membrane is affected by sPLA2-IIA both
through a modiﬁcation in the melting events in the membrane and by
alternating the level of lipid ﬂuidity.
Fig. 4 shows the thermotropic phase behavior of bacterial
membranes treated with sPLA2-IIA at three different temperatures
(10 °C, 28 °C, and 34 °C). Fig. 4a shows a superposition of the raw
thermal proﬁles at different temperatures, and Fig. 4b shows the ﬁrst
derivative of these thermal proﬁles. Cells were exposed at the shown
temperatures for 30 minutes, and the reaction was quenched by
adding EDTA. Thepresence of either the hydrolysis buffer or EDTAdoes
not affect the original phase behavior (data not shown) and does not
change the position of the cooperative thermal events (see Table 2,
Supplementary information). The hydrolysis process results in the
generation of fatty acids and lysolipids. It has been previously shown
through neutron diffraction experiments that, during the hydrolytic
Fig. 4. Comparison of the thermotropic melting behavior of S. aureus before and after
sPLA2-IIA treatment at three different temperatures. (a) CH2 stretch wave number
versus temperature plots show a change in the level of ﬂuidity of the membrane after
sPLA2-IIA treatment. (b) The ﬁrst derivative of wave number versus temperature plots
shows the splitting of the main cooperative thermal event after sPLA2-IIA treatment.
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lysolipids leave themembrane surface [48,49]. Fatty acid accumulation
will have a strong effect on the lipid melting proﬁle. Owing to the lack
of a head group, the fatty acids should have a tendency to aggregate
strongly and, therefore, should appear as a high melting cooperative
event. The cells are centrifuged after treatment, so we expect that the
suspended lysolipids are removed through this process. At the three
treatment temperatures, we observed the emergence of a newmelting
event at approximately 23 °C (see Fig. 4b).
From Fig. 4a, it is clear that, in the low temperature range around
0 °C, the three treated systems showed a general rigidiﬁcation
compared to the untreated control. This is indicated by a reduction in
the CH2 stretch wave number of around 0.5 cm−1 (from 2851.00±
0.02 to 2850.48±0.03). It is interesting to observe that the reduction
in the wave number is very similar for the three treatment
temperatures analyzed, which suggests that the level of lipid packing
in the so phase may have reached a limiting value. In contrast, at high
temperatures around 40 °C, the hydrolysis generates an increasing
value in the CH2 stretch wave number for the three treatment
temperatures (see Fig. 4a).
4. Discussion
4.1. Cell membrane thermodynamic behavior and PLA2 activity:
A contrast between eukaryotic and bacterial membranes
Most studies on PLA2 sensitivity to membrane thermodynamic
behavior have focused on model membrane systems [25,28,46,50–56].These and other studies have generated an overall understanding of the
thermodynamic aspects in membranes that regulate enzyme activity.
However, there have only been a few attempts to move beyond the
model systems to try to address the interrelation between the
thermodynamic behavior of cells in vivo and PLA2 activity. This lack of
studies appears to be because the complex composition of biomem-
branes results in a rich thermodynamic behavior, which is more
difﬁcult to track compared to the model systems. This limitation has
slowed the effort of translating the ﬁndings frommodel systems to real
cell systems.
Within this context, however, it is important to note the steady
progress that has been accomplished in a series of papers studying the
interaction of PLA2 with human erythrocyte membranes [24,26,57].
Through careful analysis of enzyme kinetics, and complementary
ﬂuorescence measurements, it was shown that the catalytic step
involving the “jumping” of the lipid into the active site of the enzyme
was directly inﬂuenced by the level of lipid packing in the erythrocyte
membrane [24]. The jump rate was also shown to be rate-limiting and
therefore crucial in determining the overall rate of the reaction. These
results showed in a real cell system that the catalytic activity of the
enzyme could be modulated through factors that would inﬂuence the
level of lipid packing. For example, an inﬂux of calcium was shown to
generate heterogeneities in the erythrocyte membrane, which
triggered an increase in enzyme activity [26]. Increased activity was
shown to occur in parallel to an increase in the ability of NBD probe
lipids to leave the membrane surface, which indicated a correlation
between an increase in the jump rate and an increase in the enzyme
activity. The thermodynamic behavior and cholesterol content of the
erythrocyte membrane was also shown to play an important role in
determining enzyme activity [24,57]. It was shown that, for
temperatures where the membranes had weaker lipid–lipid inter-
actions, the erythrocyte membranes becamemore susceptible to PLA2
[24]. Also, variations in cholesterol content generated differences in
susceptibility to the enzyme [57]. These earlier results with
erythrocyte membranes have been extended to apoptotic cell lines
by the same group, with results that appear consistent with the
ﬁndings with erythrocyte membranes [58].
Heterogeneities in cell membranes, which result in increased
susceptibility to PLA2 activity, are likely to arise from nanoscopic
coexistence of lo/ld phases [59]. Within this perspective, it becomes
apparent that by tracing out the compositional and thermal regions
where nanoscopic phase coexistence is generated, a map of PLA2
susceptibility would also emerge. However, even in model systems,
for systems containing cholesterol, there is still some controversy on
the size of the compositional regions where phase separation is
expected and on the scale of phase separation [60–62]. In addition, the
task of mapping phase coexistence in real cell systems compared to
model membranes is more challenging. Nevertheless, a recent study
has made some leeway by combining several ﬂuorescent reporters
and through stepwise extraction of cholesterol [57]. This has yielded
some information on where the increased susceptibility regions
would be located. However, there is still work to be done both in
model systems and in real cell systems to understand the scale and
level of phase coexistence in cells, and the circumstances in which
they would arise. In turn, this information will yield a clear picture of
PLA2 susceptibility.
S. aureusmembranes present a different andmore straightforward
interrelation between sPLA2-IIA activity and lipid thermotropic
behavior compared to eukaryotic cells. First of all, bacteria lack
cholesterol, and this greatly simpliﬁes the phase behavior of lipid
membranes. In the absence of cholesterol, no lo phase is expected to
form, and the two prevalent lamellar lipid phases that are present
would be so and ld [63]. Therefore, while eukaryotic cell membranes
have the potential of forming three distinct lipid phases in any
combination [60], the lipids in S. aureus membranes only present a
solid-ordered state and a liquid-disordered state separated by a broad
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reported previously in model systems [25], and evidenced by the
current study (Fig. 2), sPLA2-IIA activity in the presence of membranes
enriched in DMPG appears to be regulated primarily by the phase state
of the lipids in the membrane and not by the presence of membrane
heterogeneities.
It has been shown that PLA2 activity is maximized at the heat
capacity maximum in the case of zwitterionic membranes such as
DPPC treated with snake venom PLA2. In a previous publication [25],
we evaluated whether a maximum in activity also occurred at the
melting temperature in anionic membranes (DMPG). We found that,
in the case of DMPG, both snake venom PLA2 and sPLA2-IIA showed
increased activity only in relation to the chain order state of the lipids
in the membrane and not in correlation with the heat capacity
maximum. Since both enzymes present the same behavior, we
attribute this divergence from the classical model to the anionic
nature of the membranes. For this reason, it was not surprising when
it was observed that sPLA2-IIA activity in S. aureus was similar to the
DMPG results, since the bacterial membranes are enriched in PG.
Compared to the level of heterogeneity in the membrane, the
chain order state of the lipids in the membrane is simpler to track as
seen in Fig. 1. In addition, the hydrolysis rate appears to be directly
related to the proportion of ld phase in the bacterial membrane
(Fig. 2d). Within this context, S. aureusmembranes can manage their
susceptibility to sPLA2-IIA simply by increasing the level of ordered
lipids in the membrane, which may be accomplished by synthesizing
saturated lipids [64]. There is an intrinsic advantage to this in the
context of bacterial resistance. It is more straightforward to control
the proportion of so phase in the membrane than to attempt to
regulate the level of heterogeneity. The level of heterogeneity is
highly sensitive to temperature and composition and is likely to vary
signiﬁcantly with environmental conditions.
4.2. Modiﬁcation of the physical state of the bacterial membrane through
sPLA2-IIA activity
Previous studies have shown that S. aureus can tolerate a
hydrolytic insult by sPLA2-IIA [45,65]. However, although the bacteria
may survive this hydrolytic process, the insertion of the products of
hydrolysis must have a direct effect on the physical properties of their
membrane. These physical modiﬁcations should inﬂuence membrane
malleability and function and may affect cell growth without
necessarily inducing cell death. As shown in Fig. 4. the lipid melting
proﬁle of S. aureus membranes changes signiﬁcantly after hydrolysis.
The main phase transition splits into two smaller cooperative events.
Careful inspection of the lipid melting proﬁle after treatment at three
different temperatures shows that the high temperature melting
event becomes more prevalent when cells are treated at 34 °C
compared to 10 °C (Fig. 4b). We have shown in Fig. 2 that the
hydrolytic activity of sPLA2-IIA is higher at 34 °C compared to 10 °C.
The higher temperature melting event must therefore be related to
the formation of products of hydrolysis, which aggregate to form so
phase domains with a higher melting temperature. These domains
most likely correspond to fatty acid-rich populations that remain in
the membrane [49].
In addition to generating lipid phase separation, sPLA2-IIA activity
also directly affects membrane ﬂuidity. In the so phase temperature
regime (below 5 °C), an increase in membrane rigidity is observed
after PLA2 treatment, which is evidenced by a decrease in the CH2
stretch wave number (Fig. 4a). Fatty acids lack a head group, which
should augment chain–chain interactions, and generate a high level of
membrane packing in the so phase regime. This may be explained by
the accumulation of fatty acids, which decreases the average level of
gauche rotomers by increasing the level of packing at low tempera-
tures. Since FTIR only provides the average CH2 stretch level, it is not
possible to discern from the data whether the level of lipid packingincreases overall or only in regions enriched in fatty acids. On the
other hand, membrane ﬂuidity increases in the ld phase temperature
regime (above 25 °C) after sPLA2-IIA treatment (Fig. 4a). At a high
temperature, the presence of products of hydrolysis increases the
average level of gauche rotomers as detected by the increase in the
CH2 stretch wave number. It is unclear what would be the molecular
conﬁguration of the products of hydrolysis that would lead to this
increase in the CH2 stretch wave number. Changes in membrane
packing have also been observed in DMPC giant unilamellar vesicles
(GUV) during treatment with Crotalus atrox venom PLA2 [27]. The
GUVs presented an increase in membrane packing measured by
monitoring the generalized polarization (GP) of LAURDAN. It is
important to point out that the increase in membrane packing was
measured when treating the vesicles only a few degrees higher than
the main phase transition of DMPC. Therefore, this increase in
LAURDAN GP could be a result of an upward shift in the phase
transition temperature induced by the accumulation of hydrolysis
products.
Although this workmainly focuses on the reduction of cell viability
due to enzyme activity, the results regarding the modiﬁcation of
membrane physical properties induced by the enzyme may have an
effect on bacterial proliferation even for nonlethal doses of sPLA2-IIA.
The presence of so phase in the membrane can curtail cell division
rates drastically [12]. For this reason, the formation of so phase
domains induced by sPLA2-IIA activity may have strong implications
on the bacterial growth rate. Bacterial growth curves at nonlethal
levels of sPLA2-IIA would be necessary to investigate these aspects.
However, these measurements go beyond the scope of the present
work and will be left for a future study.
4.3. Bacterial membrane phase behavior as a regulator of resistance to
sPLA2-IIA antibacterial activity
Throughout the surge in the last few years of studies onmembrane
phase behavior and domain formation in eukaryotic cells, bacterial
membranes have not received much attention. One of the main
reasons for this is the absence of cholesterol in bacteria, which implies
that bacterial membranes are unable to form the physiologically
relevant lo phase and are therefore restricted to the so and ld phases.
The lo and ld phases in eukaryotic cells both have comparable
diffusion coefﬁcients and present a liquid-like behavior in two
dimensions [66]. so/ld coexistence lends itself to the presence of
lipid domains that may function as regulators of the distribution of
membrane proteins based on their afﬁnities towards these different
phases [66]. Membrane proteins can partition in either phase and still
maintain a high level of mobility necessary for maintaining inter-
actions with other proteins. The so phase is very immobile, presenting
diffusion coefﬁcients that are several orders of magnitude lower than
the ld phase [67]. Due to this restricted mobility, so phase domains do
not lend themselves to assist in the dynamic partitioning and
organization of transmembrane proteins. In addition, the presence
of the so phase is likely to restrict membrane malleability. In fact, it
was reported that the maximum amount of so phase that can be
present in the membrane of E. coli, while still allowing for growth, is
around 20% [12].
It is therefore difﬁcult to identify a physiologically relevant process
that justiﬁes the presence of a broad so/ld melting event close to the
bacterial growth temperatures. However, bacteria invest metabolic
energy in maintaining this high temperature melting event, which
suggests that access to the so phase must serve a physiologically
useful role [12,45]. Here we show that the presence of lipids in the so
state in the bacterial membrane may act as a mechanism to generate
resistance towards the antibacterial activity of sPLA2-IIA. This
protection would not be present at 37 °C, since at this temperature,
the bacterial lipids would be fully in the ld state. However, formation
of the lipids in the so state may become a signiﬁcant resistance factor
1027J. Ocampo et al. / Biochimica et Biophysica Acta 1798 (2010) 1021–1028during bronchopulmonary and cutaneous infections where tempera-
tures may be lower depending on environmental conditions. Bacteria
may sacriﬁce optimal membrane growth conditions to generate
resistance. On the other hand, fever conditions, which have been
shown to improve the immune response to bacterial infection [68],
would be expected to increase both enzyme activity and bacterial
membrane susceptibility. It is important to note that survival rates do
not exceed 60% of the control value in the so phase after treatment
with sPLA2-IIA. However, it should be noted that a residual level of
enzyme activity is present at lower temperatures (Fig. 3). This
suggests that sPLA2-IIA presents residual activity towards bacterial
membranes in the so phase in spite of its high level of lipid packing.
This result correlates well with a previous study on model systems,
showing that for DMPG vesicles the activity of sPLA2-IIA in the so
phase remains at 20% of the activity in the ld phase [25]. The so phase
therefore generates improved resistance but not necessarily immu-
nity to sPLA2-IIA activity. Future studies should focus on whether
S. aureus can modulate its melting behavior to optimize its resistance
to sPLA2-IIA activity.
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